# FDA Warning Letter: MedisourceRx
> 2026-02-24 · Center for Drug Evaluation and Research (CDER) · `8e9ba1b617573814`
## Letter
- **Company:** MedisourceRx
- **Posted Date:** 2026-02-24
- **Letter Issue Date:** 2025-12-12
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
Compounding Pharmacy/Adulterated Drug Products
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*